Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Rohto Pharmaceutical Co Ltd (RPHCF)
OTHER OTC:RPHCF
RESEARCH TOOLSreports
Holding RPHCF?
Track your performance easily
RPHCF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$16.32 - $28.23
Previous Close$22.2
Volume35.00
Average Volume (3M)N/A
Market Cap
$5.14B
Enterprise Value$4.78B
Total Cash (Recent Filing)¥77.64B
Total Debt (Recent Filing)¥15.70B
Price to Earnings (P/E)24.9
Beta-0.03
Next Earnings
Nov 13, 2024EPS Estimate
$0.23Last Dividend Ex-Date
Sep 27, 2024Dividend Yield0.95%
Share Statistics
EPS (TTM)0.89
Shares OutstandingN/A
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard Deviation0.15
R-Squared0.03
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)2.81
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$25.33Price Target Upside17.58% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Rohto Pharmaceutical Co News
PremiumCompany Announcements
Rohto Pharmaceutical Reports Mixed H1 Financial Results
PremiumCompany Announcements
Rohto Pharmaceutical Sees Profit Decline Amid Sales Growth
PremiumCompany Announcements
Rohto Pharma Reports Strong Q1 Growth and Dividend Hike
PremiumCompany Announcements
Rohto Pharma Raises Forecast and Dividends
PremiumCompany Announcements
Rohto Pharmaceutical Sees Growth and Dividend Revision
PremiumCompany Announcements
Rohto Pharmaceutical Sees Robust Q1 Growth, Ups Dividend
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
11.97% Mutual Funds
― Other Institutional Investors
83.35% Public Companies and
Individual Investors
RPHCF FAQ
What was Rohto Pharmaceutical Co Ltd’s price range in the past 12 months?
Rohto Pharmaceutical Co Ltd lowest stock price was $16.32 and its highest was $28.23 in the past 12 months.
What is Rohto Pharmaceutical Co Ltd’s market cap?
Currently, no data Available
When is Rohto Pharmaceutical Co Ltd’s upcoming earnings report date?
Rohto Pharmaceutical Co Ltd’s upcoming earnings report date is Nov 13, 2024 which is 2 days ago.
How were Rohto Pharmaceutical Co Ltd’s earnings last quarter?
Rohto Pharmaceutical Co Ltd released its earnings results on Aug 07, 2024. The company reported $0.241 earnings per share for the quarter, missing the consensus estimate of $0.259 by -$0.018.
Is Rohto Pharmaceutical Co Ltd overvalued?
According to Wall Street analysts Rohto Pharmaceutical Co Ltd’s price is currently Undervalued.
Does Rohto Pharmaceutical Co Ltd pay dividends?
Rohto Pharmaceutical Co Ltd pays a Annually dividend of $0.1 which represents an annual dividend yield of 0.95%. See more information on Rohto Pharmaceutical Co Ltd dividends here
What is Rohto Pharmaceutical Co Ltd’s EPS estimate?
Rohto Pharmaceutical Co Ltd’s EPS estimate is $0.23.
How many shares outstanding does Rohto Pharmaceutical Co Ltd have?
Rohto Pharmaceutical Co Ltd has 236,178,310 shares outstanding.
What happened to Rohto Pharmaceutical Co Ltd’s price movement after its last earnings report?
Rohto Pharmaceutical Co Ltd reported an EPS of $0.241 in its last earnings report, missing expectations of $0.259. Following the earnings report the stock price went up 2.648%.
Which hedge fund is a major shareholder of Rohto Pharmaceutical Co Ltd?
Currently, no hedge funds are holding shares in RPHCF
---
Rohto Pharmaceutical Co Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-6.27%
12-Months-Change
Fundamentals
Return on Equity
13.00%
Trailing 12-Months
Asset Growth
15.17%
Trailing 12-Months
Company Description
Rohto Pharmaceutical Co Ltd
Rohto Pharmaceutical Co Ltd is a Japan-based manufacturer and marketer of pharmaceutical products, cosmetics, and functional foods. It undertakes manufacture and sales activities mainly in the health and beauty care categories. The company comprises the four geographical reportable segments of Japan, America, Europe, and Asia. In each segment, it manufactures and sales eye care products including eye drops and eyewash preparations, skincare products including dermal medicines, lip balm, sunscreens, and functional cosmetics, among others, internal medicines and food products including gastrointestinal medicines, traditional Chinese herbal medicines and supplements, and other products and services, such as in-vitro test kits.
---
RPHCF Stock 12 Month Forecast
Average Price Target
$25.33
▲(17.58% Upside)
Technical Analysis
Dr Reddy's Laboratories
―
Takeda Pharmaceutical Company
―
Sanofi
―
Bristol-Myers Squibb
―
Best Analysts Covering RPHCF
1 Year
1 Year Success Rate
3/4 ratings generated profit
1 Year Average Return
+0.88%
reiterated a buy rating 3 months ago
Copying Akiko Kuwahara's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +0.88% per trade.
---